Tirzepatide substance synthesis presents a complex challenge due to its specialized chemical structure. Researchers are continuously striving to optimize the production process, aiming for high yields and purity while minimizing impacts. Once synthesized, Tirzepatide API requires a robust supply chain system to ensure timely distribution to patient